|
All Oncology
Citations 101-110 of 177 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma
- H. Pels, M. Montesinos-Rongen, C. Schaller, D. Van Roost, U. Schlegel, O. D. Wiestler, and M. Deckert
Neurology 2004; 63: 167-169.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Cerebral lipiodol embolism during transcatheter arterial chemoembolization
- K. M. Yoo, B. G. Yoo, K. S. Kim, S. U. Lee, and B. H. Han
Neurology 2004; 63: 181-183.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Dysembryoplastic neuroepithelial tumors in childhood: Long-term outcome and prognostic features
- M. A. Nolan, R. Sakuta, N. Chuang, H. Otsubo, J. T. Rutka, O. C. Snead, III, C. E. Hawkins, and S. K. Weiss
Neurology 2004; 62: 2270-2276.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Molecular genetic and proteomic analysis of synchronous malignant gliomas
- Z. Zhuang, Y. -S. Lee, W. Zeng, M. Furuta, T. Valyi-Nagy, M. D. Johnson, C. L. Vnencak-Jones, R. L. Woltjer, and R. J. Weil
Neurology 2004; 62: 2316-2319.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Stroke in patients with cancer: Incidence and etiology
- D. M. Cestari, D. M. Weine, K. S. Panageas, A. Z. Segal, and L. M. DeAngelis
Neurology 2004; 62: 2025-2030.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma
- W. Wick, J. P. Steinbach, W. M. Küker, J. Dichgans, M. Bamberg, and M. Weller
Neurology 2004; 62: 2113-2115.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Doxifluridine-induced neurotoxicity with normal dihydropyrimidine dehydrogenase activity
- Dong Wook Kim, Han-Joon Kim, Dong-Eog Kim, and Jae-Kyu Roh
Neurology 2004; 62: 2136-2137.
[Full text]
[PDF]
- ARTICLES
Primary malignant brain tumor incidence and Medicaid enrollment
- P. R. Sherwood, M. Stommel, D. L. Murman, C. W. Given, and B. A. Given
Neurology 2004; 62: 1788-1793.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
L-2-hydroxyglutaric aciduria and brain malignant tumors: A predisposing condition?
- I. Moroni, M. Bugiani, L. D’Incerti, C. Maccagnano, M. Rimoldi, L. Bissola, B. Pollo, G. Finocchiaro, and G. Uziel
Neurology 2004; 62: 1882-1884.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Response of relapsed or refractory primary central nervous system lymphoma (PCNSL) to topotecan
- L. Fischer, E. Thiel, H. A. Klasen, H. Kirchen, K. Jahnke, and A. Korfel
Neurology 2004; 62: 1885-1887.
[Abstract]
[Full text]
[PDF]
|
|
